Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Cor
(NQ:
EXAS
)
50.38
-1.57 (-3.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Cor
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Why Shares of Exact Sciences Corporation Are Down This Week
August 03, 2023
The company released second-quarter earnings that were improved, but investors were unimpressed.
Via
The Motley Fool
Why Exact Sciences Stock Slumped Wednesday
August 02, 2023
The biotech's Q2 numbers were impressive overall, but Wall Street apparently wasn't satisfied.
Via
The Motley Fool
Exact Sciences Q2 Earnings Surpass Expectation, But Analyst Says Stock Has Limited Growth
August 02, 2023
Exact Sciences Corp (NASDAQ: EXAS) reported Q2 revenue of $622 million, an increase of 19%, and $617 million of core revenue, an increase of 24%, beating the
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023
August 02, 2023
Via
Benzinga
Exact Sciences (EXAS) Q2 2023 Earnings Call Transcript
August 01, 2023
EXAS earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Earnings Preview For Exact Sciences
July 31, 2023
Via
Benzinga
2 Revolutionary Stocks to Buy and Hold for 10 Years
July 22, 2023
Breaking new ground can be highly lucrative.
Via
The Motley Fool
Expert Ratings for Exact Sciences
July 21, 2023
Via
Benzinga
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
August 02, 2023
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract.
Via
Benzinga
Analyst Ratings for Exact Sciences
June 23, 2023
Via
Benzinga
Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know
June 23, 2023
Via
Benzinga
Exact Sciences, A Cathie Wood Darling, Just Reported A Sixth Big Sales Quarter
August 01, 2023
The company is a leader in using diagnostics to screen for early cancer cases.
Via
Investor's Business Daily
Accenture, Hewlett Packard Enterprise And 2 Other Stocks Insiders Are Selling
July 31, 2023
The Nasdaq 100 closed higher on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Cathie Wood's Ark Invest Continues To Sell Shares Of Warren Buffett-Backed BYD — Coinbase Holdings Trimmed As Well
July 26, 2023
Via
Benzinga
Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
July 24, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
July 24, 2023
Via
Benzinga
3 Growth Stocks Every Investor Should Know About Now
July 23, 2023
While a countless number of ideas flood the capital markets, these must-know growth stocks should be on your radar.
Via
InvestorPlace
2 Cathie Wood Growth Stocks That Could Make You Richer
July 18, 2023
These two biotechs could be winning plays for aggressive investors.
Via
The Motley Fool
Amicus Therapeutics Stock Sees Improving Market Leadership; Earns 81 RS Rating
July 17, 2023
On Monday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, to 81, up from 74 a day earlier.
Via
Investor's Business Daily
ARKK: The Pros and Cons Of Buying Into Cathie's Best-Known ETF
July 13, 2023
If you're a believer in the progress of science and technology and feel strongly that our best days are still ahead, then a slice of ARKK could be tempting.
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
ETF Returns: Mid-Cap Winners And Losers
June 28, 2023
We performed a screening of mid-cap ETFs - defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns on...
Via
Benzinga
Analysts Think This Soaring Cathie Wood Stock Has Peaked. Are They Right?
June 28, 2023
Is it a matter of time before Exact Sciences stock starts giving back some of its impressive gains this year?
Via
The Motley Fool
Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made
June 28, 2023
Via
Benzinga
This Big Cathie Wood Stock Is Outperforming Even Tesla
June 26, 2023
DraftKings is the strongest performer among Ark Invest's major holdings.
Via
Investor's Business Daily
Cologuard's Improved Performance to Accelerate Growth, Analyst Raises Expectations
June 23, 2023
Tuesday, Exact Sciences Corp (NASDAQ: EXAS) announced topline results from the pivotal BLUE-C study, showing that next-generation
Via
Benzinga
Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review
June 23, 2023
But the major indexes and leading stocks generally showed healthy action.
Via
Investor's Business Daily
Analysts Bullish On Exact Sciences' Advanced Cancer Screening
June 23, 2023
Exact Sciences sees a bump in stock price amid rising revenue and study results that show advancements to its flagship Cologuard colorectal screening product.
Via
MarketBeat
Exact Sciences Set To Dominate Emerging Precision Oncology Market: Analyst Applauds $18B Potential Market
June 22, 2023
Benchmark analyst Bruce D.
Via
Benzinga
2 Stocks to Invest $500 In and Hold For 10 Years
June 22, 2023
Both companies have outperformed the market over the past year.
Via
The Motley Fool
Exact Sciences Stock Is Trading Higher: What's Going On?
June 21, 2023
Exact Sciences Corp (NASDAQ: EXAS) shares are trading higher Wednesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.